Caliway Biopharmaceuticals Co (ROCO:6919) Price-to-Tangible-Book : 9.76 (As of Jun. 20, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Caliway Biopharmaceuticals Co Price-to-Tangible-Book?

As of today (2024-06-20), Caliway Biopharmaceuticals Co's share price is NT$524.00. Caliway Biopharmaceuticals Co's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was NT$53.71. Hence, Caliway Biopharmaceuticals Co's Price to Tangible Book Ratio of today is 9.76.

The historical rank and industry rank for Caliway Biopharmaceuticals Co's Price-to-Tangible-Book or its related term are showing as below:

ROCO:6919' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 6.48 Med: 6.83 Max: 9.76
Current: 9.76

During the past 5 years, Caliway Biopharmaceuticals Co's highest Price to Tangible Book Ratio was 9.76. The lowest was 6.48. And the median was 6.83.

ROCO:6919's Price-to-Tangible-Book is ranked worse than
86.19% of 1209 companies
in the Biotechnology industry
Industry Median: 2.63 vs ROCO:6919: 9.76

A closely related ratio is called PB Ratio. As of today, Caliway Biopharmaceuticals Co's share price is NT$524.00. Caliway Biopharmaceuticals Co's Book Value per Sharefor the quarter that ended in Dec. 2023 was NT$53.71. Hence, Caliway Biopharmaceuticals Co's P/B Ratio of today is 9.76.

Caliway Biopharmaceuticals Co Price-to-Tangible-Book Historical Data

The historical data trend for Caliway Biopharmaceuticals Co's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Caliway Biopharmaceuticals Co Price-to-Tangible-Book Chart

Caliway Biopharmaceuticals Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

6.48

7.18

Caliway Biopharmaceuticals Co Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial			-	-	6.48	23.55	7.18

Competitive Comparison of Caliway Biopharmaceuticals Co's Price-to-Tangible-Book

For the Biotechnology subindustry, Caliway Biopharmaceuticals Co's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Caliway Biopharmaceuticals Co's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Caliway Biopharmaceuticals Co's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Caliway Biopharmaceuticals Co's Price-to-Tangible-Book falls into.

Caliway Biopharmaceuticals Co Price-to-Tangible-Book Calculation

Caliway Biopharmaceuticals Co's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	524.00	/	53.711
	=	9.76

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Caliway Biopharmaceuticals Co Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Caliway Biopharmaceuticals Co's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Caliway Biopharmaceuticals Co (ROCO:6919) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Caliway Biopharmaceuticals Co Ltd (ROCO:6919) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.99, Sec. 1, Xintai 5th Road, 32F.-9, Xizhi District, New Taipei City, TWN, 221

Website

https://www.caliway.com.tw

Caliway Biopharmaceuticals Co Ltd is specialized in the development of new drugs for medical aesthetic and inflammatory diseases. Its leading candidate, CBL-514, is a new drug that can trigger adipocyte apoptosis at the injection site and effectively reduce subcutaneous fat without causing tissue necrosis or prominent side effects.

Caliway Biopharmaceuticals Co (ROCO:6919) Headlines

No Headlines